ACM Global Laboratories Unveils New Testing Services for Oncology Trials
ACM Announces New Testing Services for Oncology Trials
Sponsors—Can You Answer 6 Questions Regulators ask During Audits?
During an audit, the FDA investigates six areas to determine whether a site is in compliance with federal drug accountability regulations-can sponsors answer them?
Clinical Trial Design Survey, June 2018
Gene Therapy in Rare Disease Research
A look at home and dosing site considerations.
Hope. The Power for the Rare Disease Journey
Editor-in-Chief Lisa Henderson speak about therapeutic needs, rare diseases in children, and the SCORR Marketing survey on innovative or flexible trial designs.
Clinical Design: A Deep Dive
Findings from a new ACT and SCORR Marketing survey reveal the most actively used flexible design approaches in clinical research-many with application in rare disease.
Clinical Trial Evolution: A CRO’s Perspective
Leader of one longtime CRO discusses the marked changes in clinical trial practice from past to present-and the company’s unique focus.
Models of Engagement: Patients as Partners in Clinical Research
Exploring three distinct patient partnership models to help researchers assess which methods of engagement could work best for their clinical programs.
Any Cancer Can Be a 'Rare Cancer'
With more common cancers now increasingly broken down by specific genomic defects, the future of research for any cancer is entirely, and unequivocally, molecular.
Monoclonal Antibodies: Clinical Pharmacology Keys
Outlining the unique pharmacokinetic factors that should be considered when designing and running early stage clinical trials for monoclonal antibodies.
The Need and Opportunity for a New Paradigm in Clinical Trial Execution
Sobering statistics collected on clinical trial execution point to the eventual convergence of healthcare and clinical research operating environments.
Applied Clinical Trials, June 2018 Issue (PDF)
Click the title above to open the Applied Clinical Trials June 2018 issue in an interactive PDF format.
The University Hospital Center Zagreb, Croatia, joins Clinerion’s global network of hospitals.
The University Hospital Center Zagreb Joins Clinerion’s Network of Hospitals
OmniComm Introduces TrialMaster Version 5, the Mobile-Friendly EDC Solution for Clinical Trials
OmniComm Releases TrialMaster Version 5, EDC Solution for Clinical Trials
Elligo Health Research Announces Acquisition of ePatientFinder's Platforms
Elligo Health Research Announces Acquisition of ePatientFinder Clinical Trial Exchange Technology Platform and Practice Network
Adaptive Clinical Systems Partners with OmniComm
Adaptive Clinical Systems® Partners with OmniComm to Offer EDC Integration Platform
Novartis Researches Novel Digital Biomarkers
John Reites, THREAD’s Chief Product Officer, will discuss eDROs and the FocalView App in this interview.
New “Right-to-Try” Law Challenges FDA Oversight
Right-to-Try bill sent to White House for President’s signature after passage by Congress.
WCG (WIRB-Copernicus Group) Clinical Services Division Opens Office in Japan
New Weapons and new Warnings Over Health Research
Artificial intelligence is a "new weapon" in healthcare research.
WCG Clinical Services Division Opens Office in Japan
Saama Technologies and ICON Commercialization and Outcomes Partner to Unlock the Value of Real World Evidence (RWE)
Saama Technologies and ICON Partner to Unlock the Value of RWE
CRA Skills Lacking in Critical Areas
A global CRO’s data gathered using an objective monitoring simulation administered by CRA Assessments, LLC reveals that CRAs are consistently underperforming regardless of the level of experience or training.
Gene Therapy in Rare Diseases: Home and Dosing Site Considerations
With the rise in gene therapies entering clinical trials, it is important to address the operational challenges associated with these types of trials.
